Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | CMA1 | P23946 | 12/20 | 0.44 |
| ▸ | ELANE | P08246 | 6/20 | 0.43 |
| ▸ | CTRC | Q99895 | 4/20 | 0.43 |
| ▸ | CTSG | P08311 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30765493 | 0.92 | BCHE (0.44) | BCHECMA1ELANECTRC | |
| SCHEMBL30765771 | 0.88 | ELANE (0.44) | CMA1ELANECTRC | |
| SCHEMBL30765813 | 0.83 | ELANE (0.42) | BCHEELANE | |
| SCHEMBL30765568 | 0.82 | ELANE (0.43) | CMA1ELANECTRC | |
| SCHEMBL30765664 | 0.81 | BCHE (0.44) | BCHEELANE | |
| SCHEMBL30766052 | 0.79 | KLK7 (0.42) | BCHEELANE | |
| SCHEMBL30765638 | 0.78 | GAA (0.41) | BCHEELANE | |
| SCHEMBL30765599 | 0.77 | CTRC (0.54) | CMA1ELANECTRC | |
| SCHEMBL30765856 | 0.77 | KLK7 (0.40) | BCHEELANE | |
| SCHEMBL6804164 | 0.75 | CMA1 (0.48) | CMA1ELANECTRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4568666-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | Alexion Pharmaceuticals, Inc. (US) | 2025-06-18 | — | — | EP | disclosed |
| WO-2024035686-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2024-02-15 | — | — | WO | disclosed |